Clinical Impact of Dual Time Point <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer

Clinical Impact of Dual Time Point <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer

We examined the value of preoperative dual time point (DTP) <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (FDG PET/CT) as a predictor of early recurrence or the outcomes in patients with pancreatic cancer. Standardized uptake values (SU...

Full description

Bibliographic Details
Main Authors: Takahiro Einama, Yoji Yamagishi, Yasuhiro Takihata, Fukumi Konno, Kazuki Kobayashi, Naoto Yonamine, Ibuki Fujinuma, Takazumi Tsunenari, Keita Kouzu, Akiko Nakazawa, Toshimitsu Iwasaki, Eiji Shinto, Jiro Ishida, Hideki Ueno, Yoji Kishi
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
pancreatic cancer
dual time point PET/CT
SUVmax1
SUVmax2
ΔSUVmax%
Online Access:https://www.mdpi.com/2072-6694/14/15/3688

Internet

https://www.mdpi.com/2072-6694/14/15/3688

Similar Items